Exploring the Impact of Global Health Initiatives on Alzheimer’s

Exploring the Impact of Global Health Initiatives on Alzheimer’s

### Exploring the Impact of Global Health Initiatives on Alzheimer’s

Alzheimer’s disease is a growing global health concern, affecting millions of people worldwide. The disease is characterized by memory loss, confusion, and difficulty with communication and problem-solving. Despite its prevalence, there is still no cure for Alzheimer’s, but various global health initiatives are working to improve diagnosis, treatment, and prevention.

#### The Brain Health Navigator Program

One significant initiative is the Brain Health Navigator program, launched by the Davos Alzheimer’s Collaborative (DAC). This program aims to improve access to the latest treatments for Alzheimer’s disease and enhance patient outcomes. Dartmouth Health is one of six health systems nationally participating in this program, which seeks to coordinate care and ensure that eligible patients receive disease-modifying therapies during the early stages of the disease[1].

#### Understanding the Scope of the Disease

Alzheimer’s disease is a major cause of disability and dependency among older people globally. Every three seconds, someone in the world develops dementia, and nearly 10 million new cases occur each year. The disease affects over 55 million people worldwide, with this number expected to rise to 78 million by 2030 and 139 million by 2050[2]. The disease is particularly prevalent in low- and middle-income countries, where access to healthcare and diagnostic tools is often limited.

#### The Financial Burden

The financial impact of Alzheimer’s disease is substantial. In 2022, the estimated healthcare costs associated with treating Alzheimer’s were $321 billion, with costs projected to exceed $1 trillion by 2050. These costs are largely borne by patients and their families, as well as by Medicare and Medicaid[2]. The total lifetime cost of care for a patient with dementia is estimated at $412,936, with 70% of these costs being unpaid caregiving and out-of-pocket expenses.

#### Research and Prevention Efforts

Researchers are actively working to understand the causes of Alzheimer’s and develop new treatments. The Alzheimer’s Association has committed a record $109 million to research in 2024, including grants for new scientific investigations[5]. The U.S. POINTER study is one such initiative, aiming to understand the relationship between lifestyle interventions and dementia risk. This study has enrolled over 2,000 participants from diverse backgrounds and is expected to provide valuable insights into preventing the disease[5].

#### International Trials

Another significant effort is the international Alzheimer’s prevention trial in young adults, which began in 2025. This trial, funded by the NIH’s National Institute on Aging and the Alzheimer’s Association, aims to prevent the buildup of Alzheimer’s pathology before it starts. The trial involves members of families that carry dominant Alzheimer’s mutations and is expected to significantly impact how we prevent Alzheimer’s disease[3].

#### Community Engagement

Community engagement is also crucial in addressing Alzheimer’s. The MIND Center at the University of Mississippi Medical Center is working to find new ways to slow or prevent dementia. The center’s research team has analyzed data from the long-running Atherosclerosis Risk in Communities (ARIC) Study, which has tracked heart health and cognitive function in its participants since the late 1980s. The findings highlight the importance of early risk factor identification and the development of interventions to preserve brain function and promote healthy aging[4].

### Conclusion

Global health initiatives like the Brain Health Navigator program, research studies, and community engagement efforts are crucial in addressing the impact of Alzheimer’s disease. These initiatives aim to improve diagnosis, treatment, and prevention, ultimately reducing the burden of this devastating disease on individuals and families worldwide. By continuing to invest in research and community programs, we can work towards a future where Alzheimer’s is no longer a major public health concern.